ha 1004 and thromboxane a2

ha 1004 has been researched along with thromboxane a2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Crowley, MR; Fineman, JR; Soifer, SJ	1

Other Studies

1 other study(ies) available for ha 1004 and thromboxane a2

Article	Year
HA1004, an intracellular calcium antagonist, selectively attenuates pulmonary hypertension in newborn lambs. Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:5 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Calcium Channel Blockers; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Infusions, Intravenous; Isoquinolines; Muscle Relaxation; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Protein Kinase Inhibitors; Pulmonary Alveoli; Regression Analysis; Sheep; Sulfonamides; Thromboxane A2	1994

Article

Year

HA1004, an intracellular calcium antagonist, selectively attenuates pulmonary hypertension in newborn lambs.

Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:5

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Calcium Channel Blockers; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Infusions, Intravenous; Isoquinolines; Muscle Relaxation; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Protein Kinase Inhibitors; Pulmonary Alveoli; Regression Analysis; Sheep; Sulfonamides; Thromboxane A2

1994